Suchergebnisse - "BNT162 vaccine"

PubPharm (3.928)

31

Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls

enthalten in: The Journal of rheumatology | 2024

von Eviatar, T. | Furer, V. | Polachek, A. | +14

32

Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines : a nationwide cohort study using an emulated target trial approach

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Choi, M. | Na, Y. | Hyun, H. | +10

33

Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKD

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2024

von Cheng, F. | Yan, V. | Wan, E. | +9

34

Relative deficiency in interferon-γ-secreting CD4+ T cells is strongly associated with poorer COVID-19 vaccination responses in older adults

enthalten in: Aging cell | 2024

von Ho, V. | Boon, L. | Cui, J. | +38

35

Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy

enthalten in: Clinical and translational gastroenterology | 2024

von Caldera, F. | Rolak, S. | Farraye, F. | +9

36

Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals

enthalten in: Clinical immunology (Orlando, Fla.) | 2024

von Galeota, E. | Bevilacqua, V. | Gobbini, A. | +31

37

Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine : A Case Report

enthalten in: JBJS case connector | 2024

von Yilmaz, A. | Goker, B. | Gedikoglu, M. | +2

38

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination

enthalten in: JAMA network open | 2024

von Gorochov, G. | Ropers, J. | Launay, O. | +32

39

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years

enthalten in: JAMA network open | 2024

von Hu, M. | Shoaibi, A. | Feng, Y. | +23

40

Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico

enthalten in: Viruses | 2024

von Ventura-Enríquez, Y. | Cortina-De la Rosa, E. | Díaz-Padilla, E. | +4